Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivity

Moderate exercise decreases the risk for atrial fibrillation (AF), an effect which is probably mediated via exercise-stimulated release of exerkines. β-Aminoisobutyric acid (BAIBA), a novel exerkine, has been reported to provide protective benefits against many cardiovascular diseases, yet its role...

Full description

Bibliographic Details
Main Authors: Xinghua Qin, Peng Liu, Lingyan Jin, Ke Zhu, Yuanqing Yang, Zuoxu Hou, Huiliang Zhang, Qiangsun Zheng
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332224000180
_version_ 1797324328393506816
author Xinghua Qin
Peng Liu
Lingyan Jin
Ke Zhu
Yuanqing Yang
Zuoxu Hou
Huiliang Zhang
Qiangsun Zheng
author_facet Xinghua Qin
Peng Liu
Lingyan Jin
Ke Zhu
Yuanqing Yang
Zuoxu Hou
Huiliang Zhang
Qiangsun Zheng
author_sort Xinghua Qin
collection DOAJ
description Moderate exercise decreases the risk for atrial fibrillation (AF), an effect which is probably mediated via exercise-stimulated release of exerkines. β-Aminoisobutyric acid (BAIBA), a novel exerkine, has been reported to provide protective benefits against many cardiovascular diseases, yet its role in AF remains elusive. Herein, using a mouse model of obesity-related AF through high-fat diet (HFD) feeding, we found that 12-week drinking administration of BAIBA (170 mg/kg/day) decreased AF susceptibility in obese mice. Atrial remodeling assessment showed that BAIBA attenuated obesity-induced atrial hypertrophy and interstitial fibrosis, thereby ablating the substrate for AF. Of note, to our knowledge, this is the first report of the direct association of BAIBA and hypertrophy. BAIBA has been reported to be a key regulator of glucose and lipid metabolism, and we found that BAIBA alleviated insulin resistance in obese mice. Transcriptional analysis of metabolism-related genes showed that BAIBA increased the transcription of fatty acids metabolism-related genes in the atria of lean mice but not in that of obese mice. Mechanistic investigation showed that BAIBA stimulated AMP-activated protein kinase (AMPK) signaling in the atria of obese mice and palmitic acid (PA)-treated neonatal rat cardiomyocytes (NRCM), whereas inhibition of AMPK via Compound C attenuated BAIBA-conferred cardioprotection against hypertrophy and insulin resistance in PA-treated NRCM. Collectively, BAIBA attenuates AF susceptibility in obese mice via activated AMPK signaling and resultant improvement of insulin sensitivity, thereby providing perspectives on the potential therapeutic role of BAIBA in AF treatment.
first_indexed 2024-03-08T05:55:32Z
format Article
id doaj.art-4b3d96a8c54c41b1b63490c56ca3fcb4
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-03-08T05:55:32Z
publishDate 2024-02-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-4b3d96a8c54c41b1b63490c56ca3fcb42024-02-05T04:31:14ZengElsevierBiomedicine & Pharmacotherapy0753-33222024-02-01171116137Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivityXinghua Qin0Peng Liu1Lingyan Jin2Ke Zhu3Yuanqing Yang4Zuoxu Hou5Huiliang Zhang6Qiangsun Zheng7Xi'an Key Laboratory of Special Medicine and Health Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; Correspondence to: School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, ChinaXi'an Key Laboratory of Special Medicine and Health Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, ChinaXi'an Key Laboratory of Special Medicine and Health Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, ChinaDepartment of Orthopedics, Shenzhen Hospital of Southern Medical University, Shenzhen 518000, ChinaDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADepartment of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China; Corresponding author.Moderate exercise decreases the risk for atrial fibrillation (AF), an effect which is probably mediated via exercise-stimulated release of exerkines. β-Aminoisobutyric acid (BAIBA), a novel exerkine, has been reported to provide protective benefits against many cardiovascular diseases, yet its role in AF remains elusive. Herein, using a mouse model of obesity-related AF through high-fat diet (HFD) feeding, we found that 12-week drinking administration of BAIBA (170 mg/kg/day) decreased AF susceptibility in obese mice. Atrial remodeling assessment showed that BAIBA attenuated obesity-induced atrial hypertrophy and interstitial fibrosis, thereby ablating the substrate for AF. Of note, to our knowledge, this is the first report of the direct association of BAIBA and hypertrophy. BAIBA has been reported to be a key regulator of glucose and lipid metabolism, and we found that BAIBA alleviated insulin resistance in obese mice. Transcriptional analysis of metabolism-related genes showed that BAIBA increased the transcription of fatty acids metabolism-related genes in the atria of lean mice but not in that of obese mice. Mechanistic investigation showed that BAIBA stimulated AMP-activated protein kinase (AMPK) signaling in the atria of obese mice and palmitic acid (PA)-treated neonatal rat cardiomyocytes (NRCM), whereas inhibition of AMPK via Compound C attenuated BAIBA-conferred cardioprotection against hypertrophy and insulin resistance in PA-treated NRCM. Collectively, BAIBA attenuates AF susceptibility in obese mice via activated AMPK signaling and resultant improvement of insulin sensitivity, thereby providing perspectives on the potential therapeutic role of BAIBA in AF treatment.http://www.sciencedirect.com/science/article/pii/S0753332224000180Atrial fibrillationβ-Aminoisobutyric AcidMetabolic flexibilityInsulin resistanceAMP-activated protein kinase
spellingShingle Xinghua Qin
Peng Liu
Lingyan Jin
Ke Zhu
Yuanqing Yang
Zuoxu Hou
Huiliang Zhang
Qiangsun Zheng
Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivity
Biomedicine & Pharmacotherapy
Atrial fibrillation
β-Aminoisobutyric Acid
Metabolic flexibility
Insulin resistance
AMP-activated protein kinase
title Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivity
title_full Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivity
title_fullStr Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivity
title_full_unstemmed Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivity
title_short Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivity
title_sort exerkine β aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating ampk signaling and improving insulin sensitivity
topic Atrial fibrillation
β-Aminoisobutyric Acid
Metabolic flexibility
Insulin resistance
AMP-activated protein kinase
url http://www.sciencedirect.com/science/article/pii/S0753332224000180
work_keys_str_mv AT xinghuaqin exerkinebaminoisobutyricacidprotectsagainstatrialstructuralremodelingandatrialfibrillationinobesityviaactivatingampksignalingandimprovinginsulinsensitivity
AT pengliu exerkinebaminoisobutyricacidprotectsagainstatrialstructuralremodelingandatrialfibrillationinobesityviaactivatingampksignalingandimprovinginsulinsensitivity
AT lingyanjin exerkinebaminoisobutyricacidprotectsagainstatrialstructuralremodelingandatrialfibrillationinobesityviaactivatingampksignalingandimprovinginsulinsensitivity
AT kezhu exerkinebaminoisobutyricacidprotectsagainstatrialstructuralremodelingandatrialfibrillationinobesityviaactivatingampksignalingandimprovinginsulinsensitivity
AT yuanqingyang exerkinebaminoisobutyricacidprotectsagainstatrialstructuralremodelingandatrialfibrillationinobesityviaactivatingampksignalingandimprovinginsulinsensitivity
AT zuoxuhou exerkinebaminoisobutyricacidprotectsagainstatrialstructuralremodelingandatrialfibrillationinobesityviaactivatingampksignalingandimprovinginsulinsensitivity
AT huiliangzhang exerkinebaminoisobutyricacidprotectsagainstatrialstructuralremodelingandatrialfibrillationinobesityviaactivatingampksignalingandimprovinginsulinsensitivity
AT qiangsunzheng exerkinebaminoisobutyricacidprotectsagainstatrialstructuralremodelingandatrialfibrillationinobesityviaactivatingampksignalingandimprovinginsulinsensitivity